Status
Conditions
Treatments
About
The aim of this study is to evaluate the "normal" development of cerebral cortex with quantitative measurement in low risk pregnant women
Full description
Study design:
This is a prospective study that evaluates normal fetal brain cortex development from 14 to 34 WG using 2D and 3D ultrasound in singleton low risk pregnancies with unknown obstetrical complications. The clinical and obstetrical data will be obtained prior to the US evaluation; and will include maternal medical and obstetrical data and confirmation of fetal gestational age based on first day of the last menstrual cycle (LMP) supported by well documented CRL from first trimester US. Brain biometric and sulcation analysis includes:
Two measurements will be taken by two examiners in order to evaluate intraobserver and interobserver reproducibility.
In all the cases a maximum effort will be undertake to obtain adequate volumes of the brain in order to enable offline evaluation of the different structures.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Gestation who had a singleton fetus in cephalic presentation, with well documented gestational age by first trimester US scan CRL.
Biometric measurement within 10th to 90th percentile.
Exclusion criteria
500 participants in 1 patient group
Loading...
Central trial contact
Shaton Ben Rubi, S.C; Eyal Zohav, M.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal